Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder
- 1 January 2003
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 90 (08) , 293-298
- https://doi.org/10.1160/th02-12-0323
Abstract
The Quebec Platelet Disorder (QPD) is an unusual bleeding disorder associated with increased platelet stores of urokinase-type plasminogen activator (u-PA) and proteolysis of platelet α–granule proteins. The increased u-PA and proteolyzed plasmino-gen in QPD platelets led us to investigate possible contributions of intracellular plasmin generation to QPD α-granule proteolysis. ELISA indicated there were normal amounts of plasminogen and plasmin-α2-antiplasmin (PAP) complexes in QPD plasmas. Like normal platelets, QPD platelets contained only a small proportion of the blood plasminogen, however, they contained an increased amount of PAP complexes compared to normal platelets (P < 0.005). The quantities of plasminogen stored in platelets were important to induce QPD-like proteolysis of normal α-granule proteins by two chain u-PA (tcu-PA) in vitro. Moreover, adding supplemental plasminogen to QPD, but not to control, platelet lysates, triggered further α-granule protein proteolysis to forms that comigrated with plasmin degraded proteins. These data suggest the generation of increased but limiting amounts of plasmin within platelets is involved in producing the unique phenotypic changes to α-granule proteins in QPD platelets. The QPD is the only known bleeding disorder associated with chronic, intracellular activation of the fibrinolytic cascade.Keywords
Funding Information
- Stroke Foundation of Ontario
This publication has 27 references indexed in Scilit:
- Fibrinogen degradation products in patients with the Quebec platelet disorderBritish Journal of Haematology, 1997
- Inherited disorders of platelet alpha-granulesPlatelets, 1997
- The plasminogen-plasmin systemProgress in Cardiovascular Diseases, 1991
- Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation productsBlood Coagulation & Fibrinolysis, 1990
- Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activatorCell, 1990
- Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.Journal of Clinical Investigation, 1990
- THE ORIGIN AND PHYSIOLOGICAL RELEVANCE OF α‐GRANULE ADHESIVE PROTEINSBritish Journal of Haematology, 1990
- Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets.Journal of Clinical Investigation, 1989
- Plasminogen activator inhibitor (PAI‐1) in plasma and plateletsBritish Journal of Haematology, 1988
- Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.Journal of Clinical Investigation, 1985